Phathom Pharmaceuticals, Inc. (PHAT) NASDAQ
9.97
+0.3178(+3.29%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.21B |
| Enterprise Value | 1.08B |
| P/E Ratio | -5.22 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 3.89 |
| Price/Book Ratio | -2.44 |
| Enterprise/Revenue | 3.02 |
| Enterprise/EBITDA | -6.45 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.77 |
| Operating Margin | -0.47 |
Management Effectiveness
| Return On Assets | -0.52 |
| Return On Equity | 0.39 |
Income Statement
| Revenue | 175.11M |
| Revenue/Share | 2.5 |
| Gross Profit | 152.51M |
| EBITDA | -159.35M |
| Net Income | -221.25M |
| Diluted EPS | -3.03 |
Balance Sheet
| Total Cash | 180.9M |
| Total Cash/Share | 2.2 |
| Total Debt | 2.63M |
| Total Debt/Equity | -0.01 |
| Current Ratio | 2.21 |
| Book Value Per Share | -4.11 |
Price History
| 52-Week Change | 102.03 |
| 52-Week High | 18.31 |
| 52-Week Low | 4.47 |
| Moving Average 50 Days | 11.66 |
| Moving Average 200 Days | 12.83 |
Statistics
| Average Volume | 1.22M |
| Shares Outstanding | 79.76M |
| % Held by Institutions | 94.47 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
